Literature DB >> 18955493

The actinobacterial mce4 locus encodes a steroid transporter.

William W Mohn1, Robert van der Geize, Gordon R Stewart, Sachi Okamoto, Jie Liu, Lubbert Dijkhuizen, Lindsay D Eltis.   

Abstract

Bioinformatic analyses have suggested that Mce proteins in diverse actinobacteria are components of complex ATP-binding cassette transporter systems, comprising more than eight distinct proteins. In Mycobacterium tuberculosis, these proteins are implicated in interactions of this deadly pathogen with its human host. Here, we provide direct evidence that the Mce4 system of Rhodococcus jostii RHA1 is a steroid uptake system. Transcriptional analyses indicate that the system is encoded by an 11-gene operon, up-regulated 4.0-fold during growth on cholesterol versus on pyruvate. Growth of RHA1 on cholesterol and uptake of radiolabeled cholesterol both required expression of genes in the mce4 operon encoding two permeases plus eight additional proteins of unknown function. Cholesterol uptake was ATP-dependent and exhibited Michaelis-Menten kinetics with a K(m) of 0.6 +/- 0.1 microm. This uptake system was also essential for growth of RHA1 on beta-sitosterol, 5-alpha-cholestanol, and 5-alpha-cholestanone. Bioinformatic analysis revealed that all mce4 loci in sequenced genomes are linked to steroid metabolism genes. Thus, we predict that all Mce4 systems are steroid transporters. The transport function of the Mce4 system is consistent with proposed roles of cholesterol and its metabolism in the pathogenesis of M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955493      PMCID: PMC5218832          DOI: 10.1074/jbc.M805496200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis.

Authors:  Sangwei Lu; Leah A Tager; Sadhana Chitale; Lee W Riley
Journal:  Anal Biochem       Date:  2006-02-09       Impact factor: 3.365

2.  Unmarked gene deletion mutagenesis of kstD, encoding 3-ketosteroid Delta1-dehydrogenase, in Rhodococcus erythropolis SQ1 using sacB as counter-selectable marker.

Authors:  R van der Geize; G I Hessels; R van Gerwen; P van der Meijden; L Dijkhuizen
Journal:  FEMS Microbiol Lett       Date:  2001-12-18       Impact factor: 2.742

3.  Correlating sequential homology of Mce1A, Mce2A, Mce3A and Mce4A with their possible functions in mammalian cell entry of Mycobacterium tuberculosis performing homology modeling.

Authors:  D Mitra; B Saha; D Das; H G Wiker; A K Das
Journal:  Tuberculosis (Edinb)       Date:  2005-10-26       Impact factor: 3.131

4.  Cholesterol is accumulated by mycobacteria but its degradation is limited to non-pathogenic fast-growing mycobacteria.

Authors:  Y Av-Gay; R Sobouti
Journal:  Can J Microbiol       Date:  2000-09       Impact factor: 2.419

Review 5.  Cell envelope composition and organisation in the genus Rhodococcus.

Authors:  I C Sutcliffe
Journal:  Antonie Van Leeuwenhoek       Date:  1998 Jul-Oct       Impact factor: 2.271

6.  Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon.

Authors:  Nobuyuki Shimono; Lisa Morici; Nicola Casali; Sally Cantrell; Ben Sidders; Sabine Ehrt; Lee W Riley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

7.  Genetic requirements for mycobacterial survival during infection.

Authors:  Christopher M Sassetti; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

8.  A novel system for expressing recombinant proteins over a wide temperature range from 4 to 35 degrees C.

Authors:  Nobutaka Nakashima; Tomohiro Tamura
Journal:  Biotechnol Bioeng       Date:  2004-04-20       Impact factor: 4.530

9.  Mycobacterium tuberculosis mammalian cell entry operon (mce) homologs in Mycobacterium other than tuberculosis (MOTT).

Authors:  Yoseph Haile; Dominique A Caugant; Gunnar Bjune; Harald G Wiker
Journal:  FEMS Immunol Med Microbiol       Date:  2002-06-03

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  76 in total

1.  Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1.

Authors:  Jonathan B Johnston; Arti A Singh; Anaelle A Clary; Chiung-Kuan Chen; Patricia Y Hayes; Sharon Chow; James J De Voss; Paul R Ortiz de Montellano
Journal:  Bioorg Med Chem       Date:  2012-05-11       Impact factor: 3.641

2.  An orphaned Mce-associated membrane protein of Mycobacterium tuberculosis is a virulence factor that stabilizes Mce transporters.

Authors:  Ellen Foot Perkowski; Brittany K Miller; Jessica R McCann; Jonathan Tabb Sullivan; Seidu Malik; Irving Coy Allen; Virginia Godfrey; Jennifer D Hayden; Miriam Braunstein
Journal:  Mol Microbiol       Date:  2016-02-05       Impact factor: 3.501

3.  The mycobacterial P55 efflux pump is required for optimal growth on cholesterol.

Authors:  Santiago Ramón-García; Gordon R Stewart; Zhao Kun Hui; William W Mohn; Charles J Thompson
Journal:  Virulence       Date:  2015       Impact factor: 5.882

4.  The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.

Authors:  Kirsty J McLean; Pierre Lafite; Colin Levy; Myles R Cheesman; Natalia Mast; Irina A Pikuleva; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 5.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

6.  Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations.

Authors:  Jennifer E Griffin; Amit K Pandey; Sarah A Gilmore; Valerie Mizrahi; John D McKinney; Carolyn R Bertozzi; Christopher M Sassetti
Journal:  Chem Biol       Date:  2012-02-24

7.  Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.

Authors:  Jianhua Zheng; Xianwen Ren; Candong Wei; Jian Yang; Yongfeng Hu; Liguo Liu; Xingye Xu; Jin Wang; Qi Jin
Journal:  Mol Cell Proteomics       Date:  2013-04-24       Impact factor: 5.911

8.  Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival.

Authors:  Susanne Homolka; Stefan Niemann; David G Russell; Kyle H Rohde
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

9.  7-ketocholesterol catabolism by Rhodococcus jostii RHA1.

Authors:  Jacques M Mathieu; William W Mohn; Lindsay D Eltis; Justin C LeBlanc; Gord R Stewart; Carola Dresen; Kenji Okamoto; Pedro J J Alvarez
Journal:  Appl Environ Microbiol       Date:  2009-10-30       Impact factor: 4.792

10.  Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis.

Authors:  Katherine C Yam; Igor D'Angelo; Rainer Kalscheuer; Haizhong Zhu; Jian-Xin Wang; Victor Snieckus; Lan H Ly; Paul J Converse; William R Jacobs; Natalie Strynadka; Lindsay D Eltis
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.